Assignee
CDR LIFE AG
CH·4 granted patents·7 pending applications·2 citations·filing 2019–2025
Top patents by PatentIndex Score
11 records- 0187US11912771B2MAGE-A4 peptide-MHC antigen binding proteinsCDR LIFE AG·Filed 2022·Granted Feb 27, 2024·2 cites·30 claims
- 0275US2025243266A1Anti-c3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseasesCDR LIFE AG·Filed 2024·Application pending·0 cites
- 0372US12344663B2Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseasesCDR LIFE AG·Filed 2022·Granted Jul 1, 2025·0 cites·94 claims
- 0467US12161673B2MAGE-A4 peptide dual T cell engagersCDR LIFE AG·Filed 2023·Granted Dec 10, 2024·0 cites·40 claims
- 0567US2024279344A1Mage-a4 peptide-mhc antigen binding proteinsCDR LIFE AG·Filed 2024·Application pending·0 cites
- 0666US2025144141A1Mage-a4 peptide dual t cell engagersCDR LIFE AG·Filed 2024·Application pending·0 cites
- 0757US2025002586A1Dual mhc-targeting t cell engagerCDR LIFE AG·Filed 2024·Application pending·0 cites
- 0852US2020024358A1Trispecific antigen binding proteinsCDR LIFE AG·Filed 2019·Application pending·0 cites
- 0951US2020062858A1Trispecific antigen binding proteinsCDR LIFE AG·Filed 2019·Application pending·0 cites
- 1050US12435444B2Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the sameCDR LIFE AG·Filed 2022·Granted Oct 7, 2025·0 cites·28 claims
- 1144US2025333514A1Antigen binding proteins targeting an hla-restricted prame peptideCDR LIFE AG·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CDR LIFE AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →